|
V.F. Semiglazov (1, 2), R.S. Pesotsky (1), A.I. Tseluiko (1), M.A. Dzhelyalova (1), V.S. Apollonova (1), V.V. Semiglazov (1, 3)
Search for new prognostic and predictive markers of sensitivity to endocrine therapy, chemotherapy and immunotherapy of breast cancer
|
№7 / 2021
|
|
A.V. Novik, T.L. Nekhaeva, A.I. Semenova, A.B. Danilova, D.Kh. Latipova, N.P. Pipia, G.M. Teletaeva, N.A. Avdonkina, A.Yu. Zozulya, M.L. Blokhina, A.P. Oganesyan, S.A. Protsenko, I.A. Baldueva
Ten-year experience of pharmacotherapy for soft tissue sarcomas
|
№11 / 2020
|
|
D.O. Yurlov, S.A. Protsenko, I.A. Baldueva
Predictive and prognostic markers in the treatment of patients with solid tumors
|
№7 / 2020
|
|
S.A. Protsenko, G.M. Teletaeva, E.A. Degtiareva, E.V. Levchenko, N.E. Levchenko, A.V. Mishchenko, I.A. Burovik, A.S. Artemyeva, E.N. Imyanitov, A.I. Semenova, A.V. Novik, D.Kh. Latipova
PEComas: what are the treatment options? literature review and personal experience
|
№7 / 2019
|
|
N.V. Zhukova (1), R.V. Orlova (1, 2), N.Yu. Antimonik (1), S.I. Kutukova (1, 3), N.P. Belyak (1), N.V. Popova (1)
EXPERIENCE OF TREATMENT with ANTI-PD-1: FROM WORLD STANDARDS TO REAL CLINICAL PRACTICE (CLINICAL OBSERVATION)
|
№7 / 2018
|
|
A.V. Novik
PRINCIPLES OF MODERN IMMUNOTHERAPY
|
№7 / 2018
|
|
Yu.A. Ragulin
NEOADYAVANT THERAPY OF NON-SMALL CELL LUNG CANCER: ARE THERE ANY PERSPECTIVES?
|
№8 / 2017
|
|
I.V. Nesterova (1), S.V. Kovaleva (2), G.A. Chudilova (2), L.V. Lomtatidze (2), O.N. Shinkareva (2), V.V. Malinovskaya (3)
EFFICACY AND SAFETY OF DRUG VIFERON® IN MONOTHERAPY AND COMBINED IMMUNOTHERAPY OF IMMUNOCOMPROMISED CHILDREN WITH RECURRENT RESPIRATORY INFECTIONS
|
№4 / 2017
|
|
I.V. Nesterova (1), S.V. Kovaleva (2), G.A. Chudilova (2), L.V. Lomtatidze (2), O.N. Shinkareva (2), V.V. Malinovskaya (3)
TACTICS OF REHABILITATION OF IMMUNOCOMPROMISED CHILDREN WITH RECURRENT RESPIRATORY INFECTIONS: DIFFERENTIATED APPROACHES TO INTERFERONO - AND IMMUNOTHERAPY
|
№20 / 2016
|
|
E.I. Borisova, S.L. Gutorov, M.E. Abramov
TREATMENT OF NON-SMALL CELL LUNG CANCER: THE NEXT STEP
|
№17 / 2016
|
|
M.S. Sayapina, D.A. Nosov
MODERN APPROACHES TO TREATMENT OF RENAL CELL CARCINOMA ACCORDING TO THE MATERIALS OF THE VII INTERNATIONAL CONFERENCE OF RENAL CANCER EXPERTS (CORE, 2016)
|
№8 / 2016
|
|
E.L. Savlevich, PhD in Medical Sciences
PATHOGENETIC RATIONALE FOR IMMUNOTHERAPY OF CHRONIC TONSILLITIS
|
№4 / 2015
|
Русский
